Organ allocation for liver transplantation: Is MELD the answer? North American experience

Similar documents
Improving liver allocation: MELD and PELD

Clinical Study The Impact of the Introduction of MELD on the Dynamics of the Liver Transplantation Waiting List in São Paulo, Brazil

In the United States, the Model for End-Stage Liver. Re-weighting the Model for End-Stage Liver Disease Score Components

Geographic Differences in Event Rates by Model for End-Stage Liver Disease Score

Survival Outcomes Following Liver Transplantation (SOFT) Score: A Novel Method to Predict Patient Survival Following Liver Transplantation

T here is an increasing discrepancy between the number of

Following the introduction of adult-to-adult living

The pediatric end-stage liver disease (PELD) score

ORIGINAL ARTICLE Gastroenterology & Hepatology INTRODUCTION

Development of the Allocation System for Deceased Donor Liver Transplantation

Evaluation Process for Liver Transplant Candidates

Serum Sodium and Survival Benefit of Liver Transplantation

The MELD Score in Advanced Liver Disease: Association with Clinical Portal Hypertension and Mortality

Chronic liver failure affects multiple organ systems and

ORIGINAL ARTICLE. Eric F. Martin, 1 Jonathan Huang, 3 Qun Xiang, 2 John P. Klein, 2 Jasmohan Bajaj, 4 and Kia Saeian 1

Evidence-Based Incorporation of Serum Sodium Concentration Into MELD

Dynamics of the Romanian Waiting List for Liver Transplantation after Changing Organ Allocation Policy

Disparities in Liver Transplant Allocation: An Update on MELD Allocation System

An assessment of different scoring systems in cirrhotic patients undergoing nontransplant surgery

Contraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for:

Initial approach to ascites

On February 27, 2002, the system of organ allocation

Factors associated with waiting time on the liver transplant list: an analysis of the United Network for Organ Sharing (UNOS) database

Death in patients waiting for liver transplantation. Liver Transplant Recipient Selection: MELD vs. Clinical Judgment

Liver Transplantation: The End of the Road in Chronic Hepatitis C Infection

TEMPORAL PREDICTION MODELS FOR MORTALITY RISK AMONG PATIENTS AWAITING LIVER TRANSPLANTATION

Review Article Experience Since MELD Implementation: How Does the New System Deliver?

Organ Allocation in Pennsylvania: Current concepts and future directions

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV

Learning Objectives. After attending this presentation, participants will be able to:

Denver Shunts vs TIPS for Ascites

The transplant benefit score and the national liver offering scheme

Liver and intestine transplantation: summary analysis,

Evaluating HIV Patient for Liver Transplantation. Marion G. Peters, MD Professor of Medicine University of California San Francisco USA

Patterns of abnormal LFTs and their differential diagnosis

Hepatitis C: How sick can we treat? Robert S. Brown, Jr., MD, MPH Vice Chair, Transitions of Care Interim Chief, Division of

UNIVERSITY OF CALGARY. Does the Model for End-stage Liver Disease Accurately Predict the Occurrence of

The evolution in the prioritization for liver transplantation

Patterns of abnormal LFTs and their differential diagnosis

DOTTORATO DI RICERCA IN SCIENZE MEDICO-CHIRURGICHE GASTROENTEROLOGICHE E DEI TRAPIANTI TITOLO TESI FACTORS PREDICTING MORTALITY AFTER TIPS FOR

Case 1 AND. Treatment of HCV: Pre- vs Post- Transplant. 58 yo male, ESRD/diabetic nephropathy, HD for 3 weeks

Predictors of Mortality in Long-Term Follow-Up of Patients with Terminal Alcoholic Cirrhosis: Is It Time to Accept Remodeled Scores?

Hepatic Encephalopathy Is Associated With Significantly Increased Mortality Among Patients Awaiting Liver Transplantation

Hepatopulmonary Syndrome: An Update

Evaluation Process for Liver Transplant Candidates

Scores in kidney transplantation: How can we use them?

Complication of Portal Hypertension: should the patients in the waiting list be treated differently?

Autoimmune Hepatitis: Defining the need for Liver Transplantation

See Editorial, pages

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem

Survival Benefit-Based Deceased-Donor Liver Allocation

PALLIATIVE CARE IN END-STAGE LIVER DISEASE

The New Liver Allocation System: Moving Toward Evidence-Based Transplantation Policy

ESLD a Guide for HIV Physicians. Marion Peters University of California San Francisco June 2015

Persistent Ascites and low Serum Sodium Identify Patients With Cirrhosis and Low MELD Scores Who Are at High Risk for Early Death

End-Stage Liver Disease (ESLD): A Guide for HIV Physicians

Trapianto di fegato e organi solidi. Pierluigi Toniutto Sezione di Epatologia e Trapianto Epatico Università di Udine

SERUM CYSTATIN C CONCENTRATION IS A POWERFUL PROGNOSTIC INDICATOR IN PATIENTS WITH CIRRHOTIC ASCITES

Medical Writers Circle October 2008

Since the beginning of 2002, the priority of adult. Pretransplant MELD Score and Post Liver Transplantation Survival in the UK and Ireland

Alcoholic hepatitis (AH) is an acute, inflammatory. MELD Accurately Predicts Mortality in Patients With Alcoholic Hepatitis

ASSESSMENT AND MANAGEMENT OF POTENTIAL LIVER TRANSPLANT CANDIDATES

Simultaneous Liver Kidney Allocation Policy: A Proposal to Optimize Appropriate Utilization of Scarce Resources

The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth

Over the past 6 decades, solid organ transplantation

THE MODEL FOR END-STAGE

Liver Transplantation

Management of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University

Current Liver Allocation Policies

Management of Cirrhosis Related Complications

Assessment of reproducibility of creatinine measurement and MELD scoring in four liver transplant units in the UK

Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List

Kidney, Pancreas and Liver Allocation and Distribution

ORIGINAL ARTICLE. Did the New Liver Allocation Policy Affect Waiting List Mortality?

2017 UNOS Liver Distribution Proposal Discussion: David Goldberg

4/26/2017. Liver Transplant and Palliative Care: Teaming up to improve care

T he model for end-stage liver disease (MELD) score is the

TREATMENT FOR HCC AND CHOLANGIOCARCINOMA. Shawn Pelletier, MD

Hepatology for the Nonhepatologist

Differential Simultaneous Liver and Kidney Transplant Benefit Based on Severity of Liver Damage at the Time of Transplantation

Chronic liver failure Assessment for liver transplantation

Combined Orthotopic Heart and Liver Transplantation: The Need for Exception Status Listing 1

Prognostic Significance of Ascites and Serum Sodium in Patients with Low Meld Scores

Original Article. Nutritional status and prognosis in cirrhotic patients

2014 Year End Review

Chronic Hepatic Disease

Thirty-day hospital readmission rates frequently are used as

New Organ Allocation Policy in Liver Transplantation in the United States

Liver Transplantation Evaluation: Objectives

FAIRNESS/EQUITY UTILITY/EFFICACY EFFICIENCY. The new kidney allocation system (KAS) what has it done? 9/26/2018. Disclosures

Severity and Mortality Prediction in Chronic Liver Disease using Child PUGH and MELD scales

Peri-operative challenges and long-term outcomes in liver transplantation for polycystic liver disease

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA

Portal Vein Thrombosis and Outcomes for Pediatric Liver Transplant Candidates and Recipients in the United States

Despite recent advances in the care of patients with

2017 Year End Review

Causes of Liver Disease in US

2 Biostatistics and 3 Surgery, University of Michigan, Ann

POST TRANSPLANT OUTCOMES IN PSC

Transcription:

Organ allocation for liver transplantation: Is MELD the answer? North American experience Douglas M. Heuman, MD Virginia Commonwealth University Richmond, VA, USA

March 1998: US Department of Health and Human Services issues its Final Rule Required changes in transplantation: Sickest first priority Objective listing criteria Reducing geographic disparities

The Mayo TIPS Model Malinchoc et al., 2000. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunting. Hepatology 31:864-71. Studied 231 patients undergoing TIPS for variceal bleeding (75%) or ascites (25%) Outcomes at 90 days 70 deaths 7 transplanted (censored) Multivariate analysis with Cox regression identified 4 predictors of 90 day mortality: bilirubin (B), INR, creatinine (Cr) and etiology (Et) = non-cholestatic non-alcoholic. The resulting model: Ln (Cr) x 9.57 + Ln (B) x 3.78 + Ln (INR) x11.20 +(Et) x 6.43

From Mayo TIPS model to MELD Validated as a predictor of general cirrhotic survival Modified to simplify application in the transplant setting: Give 6.4 points regardless of etiology Set minimum values of 1 for bilirubin, creatinine and INR Set maximum value of 4 for creatinine Set creatinine to 4 for patients on dialysis Round to nearest whole number Became basis for organ allocation for LT in US 2/27/02

Consequences of MELD based LT 16000 Pre Post 14000 12000 10000 8000 6000 Year-end active wait list New listings Transplants 4000 2000 0 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 Year Source: SRTR 2006 annual report and data tables www.ustransplant.org

Trends in waiting time 1825 1460 Pre Post 50th percentile (median) 1095 730 365 25th percentile 0 1996 1995 1998 1997 2000 1999 2005 2004 2003 2002 2001 Year Source: SRTR 2006 annual report and data tables www.ustransplant.org Days, from listing to transplantation (new listings)

18000 16000 14000 12000 10000 8000 6000 4000 2000 0 2500 Pre Wait list Post Consequences of MELD based LT: 2000 1500 1000 500 0 180 170 160 Wait list deaths Wait list deaths per 1000 pt years Trends in pretransplant waiting list mortality 150 140 130 120 1999 1998 1997 1996 1995 2006 2005 2004 2003 2002 2001 2000 Year Source: SRTR 2006 annual report and data tables www.ustransplant.org

One year mortality following OLT as a function of MELD Source: SRTR 2006 annual report and data tables www.ustransplant.org

Consequences of MELD based LT: Trends in post transplant mortality 20 Pre Post 15 10 5 One Year Mortality (%) Deceased Donor LT (adjusted) 0 1999 1998 1997 1996 1995 2000 2005 2004 2003 2002 2001 Source: SRTR 2006 annual report and data tables www.ustransplant.org Year

Trends in mortality: confounding factors unrelated to MELD Better outcome Increasing organ availability Increasing transplantation for hepatocellular carcinoma Better patient selection Technical improvements Worse outcome Increased recipient age Increased use of extended criteria livers

Continued evolution of MELDbased organ allocation in the U.S. 2004 Reduced priority for hepatocellular carcinoma 2005 Share 15 regional sharing to avoid transplant at MELD < 15 2006 MESSAGE conference to address MELD exceptions

Is MELD the answer? Pro Rationally derived Con Based on a nonrepresentative small sample;? recalibrate Simple Could be simpler (baseline =0, eliminate logarithms?) Accurate Poor discriminator at lower end of scale; fails to capture risk associated with ascites and hyponatremia Objective Affected by factors unrelated to severity of cirrhosis

MELD vs. CTP score Status 2 (CTP class C; n=3437) Status 2 and 3 (CTP B&C; n=6958) Note also CTP curve as shown is inconsistent with reported area under curve Wiesner et al, 2003; Gastro 124:91-6 Heuman & Mihas, 2003 Gastro 125: 992-3

Resistant ascites (R) and hyponatremia (H) are independent predictors of pretransplant mortality for patients with MELD < 21 1 MELD-AS MELD 180 day transplant-free mortality (%) 60 50 40 30 20 10 0 Neither R only H only R + H * * ** MELD < 21 MELD > 21 Hepatology 40:802-10, 2004 Sensitivity 0 0 CTP 1 - Specificity MELD-AS (supplemented with 4.5 points each for uncontrolled ascites and low sodium) was a better predictor of 180 day prelt mortality than MELD or CTP 1

Factors unrelated to cirrhosis severity that can affect MELD scores Minor (1-5 points) Lab variations in INR determination Gilbert s syndrome Prerenal azotemia (overdiuresis) Major (5 15 points) Oral anticoagulant therapy Acute biliary tract obstruction Intrinsic renal disease

Dealing with MELD distortions: oral anticoagulation Cohort: 554 cirrhotic veterans referred for OLT prior to 12/1/03. Using logistic regression, we developed a 90 day survival model incorporating Ln (bilirubin) and Ln (creatinine), omitting INR and normalized to same range as MELD MELD-XINR = 5.1 Ln (Bili) + 11.8 Ln (Cr) + 9.4 Validation: Holdout 278 veterans referred after 12/1/03 Independent UNOS wait list 11/1/01 Noncholestatic Cholestatic Heuman et al, 2007; Liver Transpl 13:30-7

Conclusion MELD is an answer, but not the answer. MELD based organ allocation has met the Final Rule requirements effect on pre or post-transplant mortality unclear MELD could be improved by recalibration and simplification inclusion of additional independent risk factors exclusion of nonhepatic influences

Everything should be made as simple as possible, but not simpler. Albert Einstein